198
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Can rituximab unlock the innate potential of checkpoint blockade in the CNS?

Pages 281-283 | Received 05 Aug 2018, Accepted 05 Aug 2018, Published online: 06 Sep 2018
 

Acknowledgments

This work was supported by the Leukemia & Lymphoma Society, by NIH R01CA139-83-01A1 and by Sandler Program for Breakthrough Biomedical Research.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at http://doi.org/10.1080/10428194.2018.1510496.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.